Ronald E. Blaylock

Founder, Managing Partner of Gennx360 Capital Partners, a private equity firm focused on investing in industrial and business services companies in the U.S. middle market, since 2006. Prior to launching Gennx360 Capital Partners, Mr. Blaylock founded and managed Blaylock & Company, an investment banking firm. Also held senior management positions at UBS, PaineWebber Group and Citicorp. Director of Advantage Solutions Inc., CarMax, Inc., and W.R. Berkley, Inc., an insurance holding company. Director of Urban One, Inc. from 2002 to 2019. Director of Syncreon U.S., a for-profit private company. Member of the Board of Trustees of Carnegie Hall. Member of the Board of Overseers of New York University Stern School of Business. Pfizer Director since 2017. Member of the Compensation and Audit Committees.